Watson Pharmaceuticals (WPI +0.1%) is close to announcing a $5.6B deal for Actavis by Wednesday,...
Watson Pharmaceuticals (WPI +0.1%) is close to announcing a $5.6B deal for Actavis by Wednesday, according to sources. The deal is an important one for Deutsche Bank (DB -3.6%), which was left holding billions of euros of Actavis debt after a leveraged buyout in 2007.
From other sites
Video at CNBC.com (Mon, 11:40AM)
at CNBC.com (Feb 18, 2015)
at CNBC.com (Feb 10, 2015)
at CNBC.com (Feb 5, 2015)
at CNBC.com (Jan 30, 2015)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs